Citation Impact
Citing Papers
Acquired Immunity to Malaria
2009
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Lack of Adherence to Evidence-based Treatment Guidelines for Nontuberculous Mycobacterial Lung Disease
2014
Early Pulmonary Resection for Mycobacterium Avium Complex Lung Disease Treated With Macrolides and Quinolones
2006
Plasmodium falciparum–Infected Erythrocytes: Agglutination by Diverse Kenyan Plasma Is Associated with Severe Disease and Young Host Age
2000
Nontuberculous mycobacteria in the setting of cystic fibrosis
2002
Azithromycin-Containing Regimens for Treatment of Mycobacterium avium Complex Lung Disease
2001
The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes
1995 Standout
Pulmonary Disease Due to Nontuberculous Mycobacteria
2008
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy
2008
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol
2001
Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
2010
Cytoadherence, pathogenesis and the infected red cell surface in Plasmodium falciparum
1999
Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
2014
Adhesive receptors on malaria-parasitized red cells
1999
Treatment of Mycobacterium avium-intracellulare complex Lung Disease With a Macrolide, Ethambutol, and Clofazimine
2003
Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes
1995
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Decoding the language of var genes and Plasmodium falciparum sequestration
2001
Intercellular adhesion molecule-1 and CD36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells.
1997
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
Nontuberculous Mycobacteria in Solid Organ Transplant Recipients
2009
The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells
2005
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
2010 Standout
An Imbalanced Learning based MDR-TB Early Warning System
2016
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
The Risk of Tuberculosis Disease Among Persons With Diabetes Mellitus: A Prospective Cohort Study
2012
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
2015
The global burden of multiple chronic conditions: A narrative review
2018 Standout
The pathogenic basis of malaria
2002 StandoutNature
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
2015
Thrice-Weekly Clarithromycin-Containing Regimen for Treatment of Mycobacterium kansasii Lung Disease: Results of a Preliminary Study
2003
The Social Determinants of Tuberculosis: From Evidence to Action
2011
Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates
2010 StandoutNobel
Therapeutic Effects of Various Initial Combinations of Chemotherapy Including Clarithromycin Against Mycobacterium avium Complex Pulmonary Disease
2009
Antimicrobial resistance: a global multifaceted phenomenon
2015 Standout
Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review
2014 Standout
Mycobacterium avium complex Pulmonary Disease in Patients Without HIV Infection
2004
Why do some African children develop severe malaria?
1991
Extensively drug-resistant tuberculosis: epidemiology and management
2014
Sulfate Metabolism in Mycobacteria
2006 StandoutNobel
Clinical and Molecular Analysis of Macrolide Resistance in Mycobacterium avium Complex Lung Disease
2006
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases
2016
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Prognostic Factors of 634 HIV-Negative Patients with Mycobacterium avium Complex Lung Disease
2011
Factors Related to Response to Intermittent Treatment of Mycobacterium avium Complex Lung Disease
2006
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Intermittent Antibiotic Therapy for Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease
2014
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013
2016 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
2012
Ethambutol Pharmacokinetic Variability Is Linked to Body Mass in Overweight, Obese, and Extremely Obese People
2011
The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden
2001 Standout
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
Antibody Recognition of Plasmodium falciparum Erythrocyte Surface Antigens in Kenya: Evidence for Rare and Prevalent Variants
1999
Molecular mechanisms of cytoadherence in malaria
1999
Young Lives Lost as B Cells Falter: What We Are Learning About Antibody Responses in Malaria
2013
Learning from class-imbalanced data: Review of methods and applications
2016 Standout
Infection Source and Epidemiology of Nontuberculous Mycobacterial Lung Disease
2018 Standout
B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice
2021 StandoutNobel
Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis
2012 StandoutNobel
Standardized Combination Antibiotic Treatment ofMycobacterium aviumComplex Lung Disease
2010
Plasmodium falciparum rosetting is associated with malaria severity in Kenya
1995 Standout
Rosette formation of Plasmodium falciparum-infected erythrocytes from patients with acute malaria
1991
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Works of Peter Cegielski being referenced
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
2012
Challenges and Controversies in Defining Totally Drug-Resistant Tuberculosis
2012
Agglutination of Plasmodium falciparum-Infected Erythrocytes from East and West African Isolates by Human Sera from Distant Geographic Regions
1992
Early Results (at 6 Months) with Intermittent Clarithromycin-Including Regimens for Lung Disease Due to Mycobacterium avium Complex
2000
A consistent log-linear relationship between tuberculosis incidence and body mass index
2009
In vitro rosetting, cytoadherence, and microagglutination properties of Plasmodium falciparum-infected erythrocytes from Gambian and Tanzanian patients
1990